Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

EPHB4

RBC: EPHB4 · Substrate: pEY · high confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Dasatinib99.30.70
Bosutinib98.80.55
Ponatinib98.50.53
Repotrectinib98.20.61
Ripretinib95.20.67
Nilotinib94.60.77
Tivozanib94.30.67
Erdafitinib89.70.74
Crizotinib88.90.58
Vandetanib87.80.72
Canertinib86.90.67
Cabozantinib84.30.75
Selpercatinib75.90.64
Nintedanib72.20.61
Dacomitinib71.40.66

Known variants

No variants catalogued.
Open in new tab